Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
Latest Dr Reddy’s Laboratories News & Updates
New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…
Mumbai, Jan 21 (IANS) Dr Reddy’s Laboratories on Wednesday reported a 14 per cent decline in its consolidated net profit for the December quarter (Q3) of FY26.The drugmaker said its consolidated net profit fell 14 per cent year-on-year (YoY) to Rs 1,209.8 crore in Q3 FY26, compared with Rs 1,413.3 crore in the same quarter last financial year, according to its stock exchange filing.Revenue from operations during the quarter rose 4.4 per cent to Rs 8,726.8 crore, up from Rs 8,358.6 crore in the y…
Mumbai, Dec 24 (IANS) Indian stock market benchmarks Sensex and Nifty ended slightly lower on Wednesday as selling pressure in oil and gas, pharmaceutical and IT stocks weighed on the indices. Trading activity also remained dull as investors stayed cautious ahead of the Christmas holiday on Thursday.The Sensex closed at 85,408.70, slipping 116.14 points or 0.14 per cent. Similarly, the Nifty ended at 26,142.10, down 35.05 points or 0.13 per cent from the previous close.“The index gravitated to…